Danaher Corporation $DHR Shares Bought by CHICAGO TRUST Co NA

CHICAGO TRUST Co NA lifted its stake in Danaher Corporation (NYSE:DHR) by 55.5% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,624 shares of the conglomerate’s stock after purchasing an additional 3,791 shares during the quarter. CHICAGO TRUST Co NA’s holdings in Danaher were worth $2,014,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Sivia Capital Partners LLC boosted its position in Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after buying an additional 119 shares during the last quarter. First Trust Advisors LP raised its position in shares of Danaher by 34.5% in the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after acquiring an additional 14,217 shares during the period. Main Street Financial Solutions LLC boosted its position in Danaher by 40.2% during the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after purchasing an additional 886 shares in the last quarter. Ieq Capital LLC lifted its position in shares of Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after buying an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC grew its position in shares of Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after purchasing an additional 325 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $193.81 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock’s 50-day moving average is $178.68 and its two-hundred day moving average is $200.76. The firm has a market cap of $137.17 billion, a price-to-earnings ratio of 37.49, a PEG ratio of 2.43 and a beta of 0.79.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the company earned $1.88 earnings per share. The company’s revenue was up 3.7% compared to the same quarter last year. Analysts predict that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on DHR shares. Citigroup started coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target on the stock. Piper Sandler assumed coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. Argus lowered their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Finally, UBS Group cut their target price on shares of Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $233.61.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.